StockVS

GP-Act III Acquisition Corp. (GPAT) Stock Analysis

Financial Services

GP-Act III Acquisition Corp.

$10.83

+$0.00 (+0.00%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

GP-Act III Acquisition Corp. operates within the financial services sector, specifically functioning as a shell company focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. As a shell company, the entity currently exists as a publicly traded vehicle awaiting a strategic business combination rather than operating a traditional revenue-generating business model. The company's market capitalization stands at $388.12M, while its annual revenue and employee count are not disclosed in available public data. This market capitalization places the company within a specific tier of financial services entities, indicating a valuation that reflects the speculative nature of pre-business-combination shell companies where revenue figures are typically N/A until a target is acquired. The lack of disclosed employee data further underscores the transitional state of the corporation, which prioritizes legal and structural readiness over operational staffing until a merger is finalized.

Financial Health

The company reports a net income of $12.30M for the trailing twelve months, despite having N/A for reported revenue and EBITDA. The significant gap between the reported net income of $12.30M and the absence of revenue figures reveals a cost structure heavily reliant on non-operating income or accounting adjustments typical of special purpose acquisition companies before a merger. The free cash flow is recorded at $-168,465, indicating that the company is currently consuming cash reserves rather than generating liquidity from operations. This negative cash flow position suggests limited financial flexibility until a business combination provides new revenue streams to offset cash burn. All three margin metrics—gross margin, operating margin, and profit margin—are listed at 0.0%, which indicates that no traditional operating revenue is being recognized to generate gross or operating profit. The company holds $145,453 in cash against total debt of $444,938, resulting in a debt-to-equity ratio that is not available due to the company's specific accounting structure. This balance sheet configuration implies a leveraged position relative to its cash on hand, as debt significantly exceeds available liquid assets. The current ratio stands at 0.45, indicating that current liabilities exceed current assets, which points to potential short-term liquidity constraints. Return on equity is not available, while return on assets is reported at -0.1%, revealing that management is currently not generating positive returns on the asset base.

Valuation Assessment

The trailing P/E ratio is 31.76, while the forward P/E ratio is not available due to the nature of the company's earnings profile. The absence of a forward P/E implies that future earnings estimates are not yet established, reflecting the uncertainty surrounding the upcoming business combination. The price-to-book ratio is -26.93, a negative figure that indicates the market is valuing the company below its book value, which is common for shell companies carrying liabilities or where the book value does not reflect the potential value of the future merger target. Price-to-sales and EV/EBITDA metrics are not available, as the company has no revenue and lacks sufficient earnings data to calculate these alternative valuation multiples. The 52-week high is $10.82 and the 52-week low is $10.30, placing the trading range in a narrow band that reflects low volatility typical of pre-merger entities. Given the proximity of the current price metrics to these bounds, the stock trades within a tight range relative to the annual high and low. The beta value is not available, preventing a direct comparison of price volatility relative to the broader market index.

Growth & Income

Revenue growth year-over-year is not available, and earnings growth year-over-year is reported at -15.1%. The negative earnings growth rate indicates a decline in profitability compared to the prior year, which is consistent with the operational model of a shell company awaiting acquisition. Since the company does not generate traditional revenue, the earnings decline does not stem from a loss of sales but rather from the structural transition period. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, any earnings generated are reinvested into the business combination process rather than distributed to shareholders. The overall growth and income profile is characterized by the absence of revenue growth metrics and a negative earnings trajectory, with no income returned to investors in the form of dividends.

Peer Comparison

GP-Act III Acquisition Corp. (GPAT) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
GP-Act III Acquisition Corp. GPAT $389.20M 34.9
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

The Shell Companies industry average P/E ratio is 82.8x. GP-Act III Acquisition Corp. trades at a P/E of 34.9.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About GP-Act III Acquisition Corp.

GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

Visit website →

Key Statistics

Market Cap
$389.20M
P/E Ratio
34.94
52-Week High
$11.21
52-Week Low
$10.42
Avg Volume
178.01K

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
United States